Methoden vergelijken
Bekijk de geselecteerde methoden naast elkaar; rijen die verschillen zijn gemarkeerd.
| Cannabis Use Disorder Identification Test× | Instrument voor Opioïdenrisico (ORT)× | |
|---|---|---|
| Vakgebied | Verslavingsgeneeskunde | Verslavingsgeneeskunde |
| Familie | Process / pipeline | Process / pipeline |
| Jaar van ontstaan≠ | 2010 | 2005 |
| Grondlegger≠ | Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman | Webster, Webster |
| Type | Self-report | Self-report |
| Oorspronkelijke bron≠ | Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60. link ↗ | Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432–442. DOI ↗ |
| Aliassen≠ | CUDIT-R, CUDIT | ORT |
| Verwant | 4 | 4 |
| Samenvatting≠ | The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions. | The ORT is a brief, 10-item self-report screening instrument designed to identify patients at elevated risk for opioid misuse, addiction, or aberrant drug-related behaviors prior to initiating opioid therapy. Developed by Webster and Webster in 2005, it stratifies patients into low, moderate, and high risk categories based on personal and family history of substance abuse, psychiatric comorbidity, and psychosocial factors. The ORT is widely used in pain management and primary care settings to guide shared decision-making and risk mitigation strategies when prescribing opioids. |
| ScholarGateGegevensset ↗ |
|
|